Prognostic Implications of Clinically Attributed Left Atrial Enlargement Subtypes in Patients Undergoing Transcatheter Aortic Valve Implantation.
- 1Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine Osaka Japan.
Abstract
Background
Left atrial enlargement (LAE) is common in patients undergoing transcatheter aortic valve implantation (TAVI), but its prognostic significance may vary according to the clinical drivers of atrial remodeling. We examined whether prognostic factors differ by clinically attributed LAE subtype in patients undergoing TAVI with preserved left ventricular ejection fraction (LVEF).Methods and results
We retrospectively analyzed 317 consecutive patients with symptomatic severe aortic stenosis (AS) undergoing TAVI who had preserved LVEF and LAE. Patients were classified as AS-associated LAE (no atrial fibrillation [AF] and <moderate mitral regurgitation [MR]) or AF/MR-associated LAE (AF and/or ≥moderate MR). The primary endpoint was all-cause death. During a median follow-up of 2.7 years, 69 patients (21.8%) died. The all-cause mortality rate was higher in the AF/MR-associated group than in the AS-associated LAE group (30.7% vs. 19.0%; log-rank P<0.01), but this association was attenuated after adjustment for eGFR, log-BNP, and LAVI. In the AS-associated LAE group, higher log-BNP (hazard ratio (HR) 1.45, 95% confidence interval (CI) 1.06-1.98), higher E/e' (HR 1.03, 95% CI 1.01-1.06), and lower TAPSE (HR 0.89, 95% CI 0.81-0.99) predicted death. In the AF/MR-associated LAE group, lower eGFR (HR 0.96, 95% CI 0.93-1.00) and higher log-BNP (HR 1.98, 95% CI 1.09-3.59) predicted death after adjustment for age. Interactions were significant for eGFR and E/e'.Conclusions
Prognostic markers after TAVI differ by clinically attributed LAE subtype, supporting subtype-informed risk stratification.
Related
- Inflammation After Transcatheter Aortic Valve Implantation: Mechanisms, Risk Stratification, and Therapeutic Implications
- Prognostic value of preprocedural neutrophil percentage-to-albumin ratio for in-hospital and overall mortality in patients with reduced ejection fraction undergoing transcatheter aortic valve implantation
- Prognostic value of pre- and post-procedural TAPSE/PASP ratio for long-term mortality in patients with left ventricular ejection fraction < 50% undergoing transcatheter aortic valve implantation
- Post-operative multi-organ dysfunction following heart transplantation and left ventricular assist device implantation: phenotypes, trajectories, and prognostic implications-a retrospective study.
- Modified balloon-assisted shoehorn technique for transcatheter aortic valve implantation in functionally horizontal anatomy: a case report
BibTeX
@article{sato2026prognostic,
title = {{Prognostic Implications of Clinically Attributed Left Atrial Enlargement Subtypes in Patients Undergoing Transcatheter Aortic Valve Implantation.}},
author = {Tatsuya Sato and Asahiro Ito and Yuki Kitagawa and Shinji Ito and Hiroki Yamaura and Akihiro Okamoto and Nanaka Nomura and Tomohiro Yamaguchi and Shunsuke Kagawa and Mana Ogawa and Takenobu Shimada and Sera Ishikawa and Yusuke Hayashi and Atsushi Shibata and Kenichiro Otsuka and Daiju Fukuda},
journal = {Circulation reports},
year = {2026},
month = sep,
doi = {10.1253/circrep.cr-26-0181},
url = {https://europepmc.org/article/MED/43011164},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Prognostic Implications of Clinically Attributed Left Atrial Enlargement Subtypes in Patients Undergoing Transcatheter Aortic Valve Implantation.
AU - Tatsuya Sato
AU - Asahiro Ito
AU - Yuki Kitagawa
AU - Shinji Ito
AU - Hiroki Yamaura
AU - Akihiro Okamoto
AU - Nanaka Nomura
AU - Tomohiro Yamaguchi
AU - Shunsuke Kagawa
AU - Mana Ogawa
AU - Takenobu Shimada
AU - Sera Ishikawa
AU - Yusuke Hayashi
AU - Atsushi Shibata
AU - Kenichiro Otsuka
AU - Daiju Fukuda
PY - 2026
DA - 2026/09/02
JO - Circulation reports
DO - 10.1253/circrep.cr-26-0181
UR - https://europepmc.org/article/MED/43011164
AB - Background Left atrial enlargement (LAE) is common in patients undergoing transcatheter aortic valve implantation (TAVI), but its prognostic significance may vary according to the clinical drivers of atrial remodeling. We examined whether prognostic factors differ by clinically attributed LAE subtype in patients undergoing TAVI with preserved left ventricular ejection fraction (LVEF).Methods and results We retrospectively analyzed 317 consecutive patients with symptomatic severe aortic stenosis (AS) undergoing TAVI who had preserved LVEF and LAE. Patients were classified as AS-associated LAE (no atrial fibrillation [AF] and <moderate mitral regurgitation [MR]) or AF/MR-associated LAE (AF and/or ≥moderate MR). The primary endpoint was all-cause death. During a median follow-up of 2.7 years, 69 patients (21.8%) died. The all-cause mortality rate was higher in the AF/MR-associated group than in the AS-associated LAE group (30.7% vs. 19.0%; log-rank P<0.01), but this association was attenuated after adjustment for eGFR, log-BNP, and LAVI. In the AS-associated LAE group, higher log-BNP (hazard ratio (HR) 1.45, 95% confidence interval (CI) 1.06-1.98), higher E/e' (HR 1.03, 95% CI 1.01-1.06), and lower TAPSE (HR 0.89, 95% CI 0.81-0.99) predicted death. In the AF/MR-associated LAE group, lower eGFR (HR 0.96, 95% CI 0.93-1.00) and higher log-BNP (HR 1.98, 95% CI 1.09-3.59) predicted death after adjustment for age. Interactions were significant for eGFR and E/e'.Conclusions Prognostic markers after TAVI differ by clinically attributed LAE subtype, supporting subtype-informed risk stratification.
SN - 2434-0790
ER -